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In most cases, apoptotic cell death culminates in the
activation of the caspase family of cysteine proteases,
leading to the orderly dismantling and elimination of
the cell. The IAPs (inhibitors of apoptosis) comprise a
family of proteins that oppose caspases and thus act to
raise the apoptotic threshold. Disruption of IAP-medi-
ated caspase inhibition has been shown to be an impor-
tant activity for pro-apoptotic proteins in Drosophila
(Reaper, HID, and Grim) and in mammalian cells (Smac/
DIABLO and Omi/HtrA2). In addition, in the case of the
fly, these proteins are able to stimulate the ubiquitina-
tion and degradation of IAPs by a mechanism involving
the ubiquitin ligase activity of the IAP itself. In this
report, we show that the Drosophila RHG proteins
(Reaper, HID, and Grim) are themselves substrates for
IAP-mediated ubiquitination. This ubiquitination of
Reaper requires IAP ubiquitin-ligase activity and a sta-
ble interaction between Reaper and the IAP. Addition-
ally, degradation of Reaper can be blocked by mutating
its potential ubiquitination sites. Most importantly, we
also show that regulation of Reaper by ubiquitination is
a significant factor in determining its biological activ-
ity. These data demonstrate a novel function for IAPs
and suggest that IAPs and Reaper-like proteins mutu-
ally control each other’s abundance.
Apoptosis is a regulated form of cell death that can be trig-
gered by a variety of intracellular and extracellular signals.
Although apoptosis research has revealed a plethora of signal-
ing pathways that can contribute to the decision of a cell to die,
the ultimate responsibility for completing the cell death pro-
gram (in most cases) resides with the cysteine proteases known
as caspases (reviewed in Refs. 1–3). Caspase-mediated cleav-
age of cellular substrates underlies many of the ordered pro-
cesses that occur as the dying cell shrinks, degrades its DNA,
and packages the remains for subsequent phagocytosis. As
such, regulation of caspase activation is a key control point for
the apoptotic machinery.
Acting in opposition to the caspases are the IAPs (inhibitors
of apoptosis). These proteins function, at least in part, by di-
rectly binding to and inhibiting active caspases (Refs. 4–6;
reviewed in Refs. 7 and 8). Many of the IAPs also contain a
RING finger domain, and like other RING finger proteins,
these IAPs can function as ubiquitin ligases (9, 10). Ubiquitin
ligases work in conjunction with ubiquitin-activating and ubiq-
uitin-conjugating enzymes to covalently link ubiquitin to ly-
sines present in the target protein. Sequential linkage of mul-
tiple ubiquitin moieties (polyubiquitination) then results in
targeting of the ubiquitinated protein for destruction by the
proteasome (reviewed in Ref. 11). Although it is well estab-
lished that IAPs can inhibit caspases through physical binding,
the significance of IAP ubiquitin-ligase activity for the anti-
apoptotic function of IAPs is not yet fully understood. For
example, IAPs have been reported to ubiquitinate and promote
the degradation of caspases, which could clearly favor cell
survival (9, 12). Conversely, IAPs can auto-ubiquitinate and
thereby promote their own destruction, which might be ex-
pected to favor cell death (9, 10, 12–17).
In Drosophila, the caspase-inhibiting function of IAPs is
antagonized by the pro-apoptotic proteins Reaper, HID, and
Grim (the RHG1 proteins). The genes encoding these proteins
are closely linked, and their combined deletion results in a
generalized failure of apoptosis during development of the Dro-
sophila embryo (18). Expression of these proteins is tightly
controlled at the level of transcription, and ectopic expression
of the RHG proteins in either insect or vertebrate cells can
initiate apoptosis (19–26). Although Reaper, HID, and Grim do
not share overall homology, they do share a short region at
their extreme N termini that is responsible for binding IAPs
(the so-called RHG motif). The interaction between the RHG
motif and the IAP has been suggested to preclude the IAP/
caspase interaction, thereby alleviating caspase inhibition (27–
30). The N-terminal RHG motif is also present in several ver-
tebrate apoptotic regulators, including Smac/Diablo and Omi/
HtrA2 (18, 19, 22, 28, 29, 31–34). As a consequence, these
proteins can directly bind and inhibit IAPs in a manner similar
to that of Reaper, HID, and Grim.
Recently, we and others have reported that Reaper, HID, and
Grim can also promote apoptosis by stimulating IAP ubiquiti-
nation and degradation (12–17). Both IAP ubiquitin-ligase ac-
tivity and the RHG motif are required for this particular inter-
action, but it is not yet clear whether other regions of the RHG
protein or the IAP will also be required. Moreover, although
Smac and Omi bind IAPs, there have been no reports that they
also stimulate IAP degradation.
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In this report, we provide evidence that the interaction be-
tween the IAPs and the RHG proteins is a two-way street with
regard to ubiquitination and proteasome-mediated degrada-
tion; that is, not only do the RHG proteins stimulate the ubiq-
uitination and degradation of IAPs, but the IAPs also stimulate
the ubiquitination and degradation of the RHG proteins. Our
data demonstrate that the RHG motif is required for IAP-
mediated degradation of Reaper, which suggests that a stable
interaction between Reaper and the IAP is required for this
form of regulation. Moreover, Reaper degradation can be
blocked by inhibiting the proteasome, and when Reaper is
stabilized by mutating potential ubiquitination sites, it be-
comes a markedly more potent inducer of apoptosis. Collec-
tively, these data indicate that IAP regulators such as Reaper
are targeted for degradation by IAP ubiquitin-ligase activity,
and that this regulation is a significant factor in determining
their biological activity.
EXPERIMENTAL PROCEDURES
Immunofluoresence and in Situ Hybridization—The following ge-
netic crosses were used to generate the imaginal discs in Fig. 1: EnG4
UAS-P35 (panels A and D), EnG4  UAS-HID, UAS-P35 (panels B, E,
and G), and EnG4  UAS-Rpr, UAS-P35 (panels C, F, H, and I). DIAP1
and HID proteins were detected by indirect antibody fluorescence using
the appropriate antibodies and standard techniques. HID and Reaper
RNAs were detected by hybridization of digoxigenin-labeled probes,
followed by dye staining.
Preparation of Recombinant Drosophila Proteins—DIAP1D20E was
prepared as described previously (43) from GST-TEV-DIAP1D20E fol-
lowed by TEV cleavage. pET23a-Reaper-GST was expressed in
BL21(DE3)pLysS by 0.4 mM isopropyl-1-thio--D-galactopyranoside for
4 h and purified using glutathione-Sepharose 4B (Amersham Bio-
sciences) per the manufacturer’s instructions. HID-His6 and Grim-His6
were purified as described previously (17). All of the proteins for in vitro
ubiquitination assays were dialyzed against the buffer UD (20 mM Tris,
pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, 10% glycerol) before use.
In Vitro Ubiquitination—Drosophila embryo extract was made as
follows. 0–5-h-old embryos were collected and aged for 6 h at 25 °C. The
embryos were dechorionated with 50% bleach, rinsed, suspended in
equal volumes of buffer EX (20 mM Tris, pH 7.5, 100 mM NaCl, 5 mM
ATP, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.25 M sucrose) and homoge-
nized. The supernatant was collected after centrifugation at 12,000 g.
The concentration of the extract was 10 g/l. The ubiquitination
assay was carried out as follows. Hid-His6, Reaper-GST, or Grim-His6
protein (100 ng each) was preincubated with 1 l of embryo extract at
room temperature for 10 min. Subsequently, DIAP1D20E (400 ng) and
His-ubiquitin (Calbiochem; 3 g total) were added in buffer UR (25 mM
Tris, pH 7.5, 0.5 mM dithiothreitol, 2 mM ATP, 5 mM MgCl2). The
reaction was incubated at 37 °C for 40 min and stopped by adding SDS
sample buffer. The ubiquitination of each protein was visualized after
separation of proteins by SDS-PAGE, transfer to polyvinylidene diflu-
oride, and immunoblotting with the appropriate antibody.
Generation of Reaper Antibody—Anti-Reaper serum was obtained by
standard immunization techniques using New Zealand White rabbits
and a synthetic Reaper C-terminal peptide conjugated to keyhole limpet
hemocyanin (Research Genetics). The sequence used for peptide syn-
thesis was CHPKTGRKSGKYRKPSQ.
Generation of ReaperKR—Reaper was cloned into pcDNA3 by stand-
ard techniques. Further work required removal of a vector MscI site;










GTTTCCAGGACGACGGTGG) were hybridized and cloned separately
into Reaper-pcDNA3PvuII to generate clones A (N-terminal mutant)
and B (C-terminal tetra-mutant). ReaperKR was generating by splicing
the BamHI/MscI fragment from clone A into clone B above, and this
insert was subcloned into the various vectors indicated.
In Vitro Translation—A variant of pcDNA3 was generated in which
a c-Myc epitope tag was cloned downstream of the MCS XbaI site. The
Reaper open reading frame minus its stop codon was cloned in frame
with the Myc tag of pcDNA3-myc using standard techniques to generate
Reaper-Myc. A variant of pSP64T, an in vitro SP6 expression vector
with flanking 5 and 3 -globin untranslated region and a polyade-
nosine tail was generated called pSP64BN. The BglII cloning site of
pSP64T was replaced with an oligonucleotide encoding the multiple
cloning site of pEBB, including unique BamHI and NotI sites. Reap-
erKR-FLAG, Reaper-FLAG, Reaper, and Reaper1–15 were subcloned
into pSP64BN by standard techniques. To produce radioactive protein
for half-life assays, Reaper-myc, Reaper, Reaper1–15, Reaper-FLAG,
ReaperKR-FLAG, Cdc25, and Grp94 templates were added at 20 ng
l1 to rabbit reticulocyte lysate (Stratagene) containing 1 Ci l1 of
S-35 Translabel (ICN), 1 (()-cysteine, ()-methionine) amino acid
mix and other components per manufacturer’s protocol. Translated
proteins were resolved by SDS-PAGE, soaked in 1 M salicylic acid for
1 h, dried, and exposed to Biomax MR film (Kodak). To assay protein
stability, 100 g ml1 cycloheximide was added to translated proteins,
which were then incubated at 30 °C for an additional 30 and 60 min,
boiled in SDS sample buffer, and processed as above.
Cell Culture, Transfections, Immunoblotting, Pulse-Chase Analysis,
and Apoptosis Assay—All of the cell culture reagents were obtained
from Invitrogen unless otherwise specified. Details of cell culture, vec-
tor constructs, immunoblotting, affinity precipitations, and pulse-chase
analysis were as previously described (14), with the following excep-
tions. HEK 293T cells were plated at a density of 1  106 cells/10-cm
dish for immunoblotting experiments and 200,000 cells/well in 6-well
dishes for pulse-chase analysis and apoptosis assay. The cells were
transfected 24 h after plating using a standard protocol of calcium
phosphate and HEPES-buffered saline. 10-cm dishes were transfected
with a total of 10 g of DNA, and 6-well plates were transfected with a
total of 1.6 g of DNA/well. Where indicated, the proteasome inhibitor
LLnL (ALLN, Calbiochem) was added to a final concentration of 20 M
for 45 min prior to harvesting cells. When appropriate, the cells were
harvested by rinsing once with phosphate-buffered saline and lysing
the cells on ice with buffer IP (50 mM HEPES, pH 7.4, 150 mM NaCl, 1
mM EDTA, 2.5 mM MgCl2, and 1% Nonidet P-40, plus 1 Complete
protease inhibitor (Roche Molecular)). Bead-bound material following
affinity precipitation was washed three times with buffer IP prior to
analysis by SDS-PAGE and immunoblotting or autoradiography. The
apoptosis-inducing ability of Reaper and ReaperKR was assayed by
co-transfecting pEGFP-C1 (Clontech) with the vectors indicated. After
48 h, live cells (as determined by forward and side scatter) were ana-
lyzed for GFP fluorescence by flow cytometry. Each transfection was
performed in duplicate, with and without 50 M zVAD-fmk (Biomol) to
inhibit caspase activation, for a total of four transfections/construct.
The percentage of live GFP cells for each construct in the absence of
zVAD-fmk was normalized to the percentage of live GFP cells in the
presence of zVAD-fmk such that the results shown indicate caspase-de-
pendent loss of GFP cells while correcting for any differences in
transfection efficiency between constructs.
SL2 Cell Culture—All of the cell culture reagents were obtained from
Invitrogen unless otherwise specified. SL2 cells were obtained from the
ATCC via the Duke Cell Culture Facility and were maintained in
Schneider’s Drosophila medium supplemented with 10% heat-inacti-
vated fetal bovine serum (HyClone). For transfection, 3  106 cells (at
5  105 cells/ml) were seeded in T-25 flasks. 24 h later, DNA was
prepared for transfection by mixing 20–30 g of appropriate constructs
with 62 l of 2 M CaCl2 and 438 l of sterile water. 500 l of 2 HEPES
buffered saline was bubbled in to each sample over 1 min. DNA mix-
tures were allowed to sit for 30 min at room temperature and were then
added to cells for 16–24 h, after which cells were pelleted and resus-
pended in fresh medium.
SL2 Killing Assay—Enhanced GFP was subcloned into the EcoRI
and XbaI sites of pCasper3, downstream of the ubiquitin promoter,
using standard techniques. Wild type Reaper and ReaperKR were
cloned into the EcoRI and BamHI sites of pMT, downstream of the
metallothionine promoter, using standard techniques. SL2 cells were
co-transfected with 2 g of GFP and 20 g of pMT vector, Reaper, or
ReaperKR. After 24 h, the cells were pelleted at 1,000 g for 5 min and
then resuspended in fresh medium. Following an additional 24 h,
Reaper or ReaperKR was induced with 70 nM CuSO4, and the cells were
incubated at 25 °C for 3 days. FACS analysis was then performed.
Transfection efficiency was controlled for by normalizing each transfec-
tion to its percentage of GFP () in the presence of zVAD-fmk. Each
transformation was analyzed in triplicate (for a total of 18 samples:
nine with zVAD-fmk and nine without). Forward and side scatter were
used to gate viable cells, with the same gate settings used for all
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samples. 100,000 gated cells/sample were counted and then analyzed
for GFP fluorescence using FACS ANALYZER (BD). Cells with 102
GFP signal were taken as positive. The percentage of survival for
sample A was calculated as [%GFP()A  zVAD-fmk]/[%GFP()A 
zVAD-fmk]. The average percentage of GFP() was calculated, and the
standard deviations for each sample were used to determine error.
1–15 versus Wild Type Stability Assay—Full-length or 1–15 reap-
er-GFP fusions were generated by overlap PCR using the following
oligonucleotides: 5 reaper, GAAGGAGGATCCATGGCAGTGGCATTC-
TACATACCC; 5 overlap, TATCGCAAGCCATCGCAAAGATCTATGG-
TGAGCAAGGGCGAG; 3 overlap, CTCGCCCTTGCTCACCATAGATC-
TTTGCGATGGCTTGCGATA; and 3 GFP, CCTCCGGATCCCTACTT-
GTACAGCTCGTCCATGCCGAG. Fusion open reading frames were
subcloned into the BamHI and EcoRI sites of pMT, downstream of the
metallothionine promoter, using standard techniques. pIE3-DIAP-HA
was a gift from Kristin White (Harvard/MGH). 10 g of DIAP and 20 g
of full-length or 1–15 reaper-GFP were transfected into SL2 cells as
described above. 24 h after resuspension in fresh medium, GFP fusions
were induced with 700 nM CuSO4 and placed into 50 M zVAD-fmk to
prevent cell death. After 16 h of induction, the cells were pelleted,
washed with fresh medium, and resuspended in medium lacking copper
but supplemented with 50 M zVAD-fmk. The cells were immediately
subjected to FACS analysis as above, with additional analyses at 16 and
24 h. Each sample was analyzed in triplicate as above. The averages
were calculated for each sample, and the standard deviations were used
to determine error. The percentage of Reaper remaining in the presence
of DIAP1  [D]/[no D] where [D]  [% GFP() with DIAP at time
T]/[% GFP() with DIAP at time 0], and [no D]  [% GFP() without
DIAP at time T]/[% GFP() without DIAP at time 0].
RESULTS
IAPs Can Ubiquitinate Reaper, HID, and Grim—Our previ-
ous work and that of others have shown that the interaction
between IAPs and Reaper (and Grim and HID) lowers cellular
IAP levels by stimulating ubiquitin-mediated degradation of
the IAPs (12–17). In the course of these experiments involving
Reaper, HID, and DIAP1, we noticed that overexpression of
Reaper in Drosophila imaginal discs led not only to lower
DIAP1 levels but also to elevated levels of HID as detected by
immunofluorescence (Fig. 1, A–F). The reciprocal experiment
examining Reaper protein levels in the presence of HID over-
expression was uninformative because of the inability of our
Reaper antibodies to detect Reaper in situ. To eliminate the
possibility that Reaper expression was affecting HID transcrip-
tion (Fig. 1F), we analyzed the amount of HID mRNA by in situ
hybridization and found that there was no increase in the
amount of HID message (Fig. 1H). These results implied that
the regulation of Reaper and HID levels were somehow linked
at a post-transcriptional step. This seemed particularly signif-
icant in light of the fact that the Reaper, HID, and Grim
proteins all play a key role in developmental and radiation-
induced apoptosis in Drosophila, but there have been no pub-
lished reports on post-transcriptional mechanisms controlling
the abundances of these proteins.
Although an effect on translational regulation remained a
possible explanation for the elevated HID levels, this seemed
unlikely because Reaper has been shown to suppress rather
than enhance translation (14, 17). However, we had also noted
that Reaper immunoprecipitates from cells transfected with
both Reaper and a human IAP (XIAP) contained a prominent
18-kDa species recognized by anti-Reaper immunoblotting.
Given the established link between the RHG proteins, IAPs,
and ubiquitin-mediated degradation, we strongly suspected
that this species was monoubiquitinated Reaper. Indeed, the
18-kDa band evident in the Reaper immunoblot of the anti-
Reaper immunoprecipitate was also recognized by anti-ubiq-
uitin antibody (Fig. 2A). Given that Drosophila IAP-1 (DIAP1)
is the physiologically relevant IAP with regard to Reaper, we
repeated these experiments with Reaper and DIAP1 with sim-
ilar results (Fig. 2A).
We then transfected cells with Reaper and either XIAP or
DIAP1 and looked for Reaper-ubiquitin conjugates in the IAP
immunoprecipitate. We detected multiple ubiquitinated spe-
cies at 9-kDa intervals above the 9-kDa nonubiquitinated
Reaper (Fig. 2B, black arrowheads). Importantly, these protein
species were absent when cells were transfected with Reaper
and an XIAP RING finger point mutant (H467A) that lacks
ubiquitin ligase activity. Note also that only the 18- and 27-kDa
species could be detected in the anti-Reaper immunoblot be-
cause the Reaper antibody was prepared against an extreme
C-terminal peptide from Reaper, where four of five ubiquitin-
modifiable lysines are located (see Fig. 5A). As such, it is likely
that multiubiquitination of Reaper was interfering with anti-
body binding.
The presence of ubiquitinated Reaper species in the IAP
co-precipitate suggested that Reaper might be a substrate of
IAP ubiquitin-ligase activity. Additionally, we suspected that
the RHG protein HID might also serve as a substrate for
IAP-mediated ubiquitination because our initial experiment
showed that HID levels increased as DIAP1 levels were low-
ered by Reaper (Fig. 1). To prove that Reaper and HID could in
fact serve as substrates for IAP-mediated ubiquitination, we
performed in vitro ubiquitination reactions with recombinant
forms of these proteins. These results show clearly that Reaper
and HID are substrates for DIAP1-stimulated ubiquitination
(Fig. 2C). Furthermore, we found that Grim is also ubiquiti-
nated in vitro (Fig. 2C), suggesting that all three of these
Drosophila RHG proteins may be regulated at the level of
protein stability.
Reaper Is Stabilized by Inhibiting the Proteasome—To fur-
ther elucidate the machinery involved with this phenomenon,
we focused on the regulation of Reaper stability and asked
whether or not the proteasome was involved in the degradation
FIG. 1. Reaper expression lowers DIAP1 levels and post-tran-
scriptionally increases HID levels. DIAP1 and HID were detected
by immunofluorescence of imaginal discs from Drosophila embryos
overexpressing p35 (A and D), HID  p35 (B and E), and Reaper  p35
(C and F). Expression of the caspase inhibitor p35 prevented Reaper-
and HID-induced apoptosis. in situ hybridization was used to detect
mRNA expression of HID (G and H) and Reaper (I).
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of ubiquitinated Reaper. When reticulocyte lysates were used
to transcribe and translate Reaper, the addition of LLnL (also
known as ALLN) to inhibit proteasomal degradation resulted
in much higher levels of Reaper production (Fig. 3A). Tran-
scription and translation of two unrelated control proteins
(cdc25 and Grp94) demonstrated that the effect of LLnL was
not a nonspecific increase in protein production (Fig. 3A). Ex-
tending these results to the more complex milieu of transfected
293T cells, we found that the addition of LLnL for 45 min
significantly increased the amount of Reaper detected by im-
munoprecipitation and immunoblotting (Fig. 3B). Both exper-
iments suggest that Reaper is targeted for proteasomal
degradation.
The Reaper N Terminus Is Required for IAP-mediated Deg-
radation—Given the ability of the RHG proteins to interact
physically with IAPs, we hypothesized that this direct binding
would be necessary for IAPs to promote Reaper, HID, and Grim
ubiquitination and degradation. To verify this, we tested a
deletion mutant of Reaper that lacked the first 15 amino acids
and was therefore missing the canonical RHG IAP-binding
motif (Reaper 1–15). In a previous report, Reaper 1–15
failed to co-precipitate with cellular IAP (24), and we have
shown that Reaper 1–15 was unable to stimulate XIAP deg-
radation (14). As expected, Reaper 1–15 failed to bind DIAP1
(Fig. 4A), whereas full-length Reaper co-precipitated with
DIAP1 quite well (Fig. 2B). Both wild type and Reaper 1–15
were then transcribed and translated in rabbit reticulocyte
lysates, and the results were analyzed by autoradiography. Our
results showed that the Reaper 1–15 protein was considerably
more abundant than the wild type, consistent with the mutant
being more stable (Fig. 4B). When cycloheximide was added to
the reticulocyte lysates to stop translation, the Reaper 1–15
protein was markedly more stable than wild type Reaper over
a 60-min time course (Fig. 4C).
FIG. 3. Proteasome-dependent degradation of Reaper. A, Myc-
tagged Reaper (Rpr-myc), Cdc25, or Grp94 were translated in the pres-
ence of 20 M LLnL or Me2SO carrier in rabbit reticulocyte lysate. For
Reaper, equal amounts of lysate were immunoprecipitated using the
9E10 anti-Myc antibody. For controls, equal volumes of lysate were
loaded for analysis. The samples were resolved by SDS-PAGE and
exposed to film. B, untagged Reaper was transfected into HEK 293T
cells that were treated for 45 min prior to harvesting with 20 M LLnL
or Me2SO carrier. The cells were harvested and subjected to immuno-
precipitation and immunoblotting using anti-Reaper serum.
FIG. 2. Reaper, Hid, and Grim ubiquitination. A, Rpr and FLAG-tagged XIAP or Reaper and GST-tagged DIAP1 were transfected into HEK
293T cells. Immunoprecipitations were performed using anti-Reaper serum coupled to protein A (IP: Rpr). The precipitates were resolved by
SDS-PAGE and blotted using anti-Reaper serum (R) or anti-ubiquitin antibody (Ub). The Reaper parent species is indicated (gray arrowhead), as
is the 18-kDa monoubiquitinated species (black arrowhead). B, Rpr and FLAG-XIAP, Rpr and FLAG-H467A XIAP ligase mutant (H467A), or Rpr
and GST-DIAP1 were transfected into HEK 293T cells. Affinity precipitations were performed using anti-FLAG antibody coupled to protein G (IP:
XIAP) or glutathione-Sepharose (IP: DIAP). The precipitates were resolved by SDS-PAGE and blotted using anti-Reaper serum (R) or anti-
ubiquitin antibody (Ub). Reaper parent species is indicated (gray arrowhead), as are the mono- and polyubiquitinated species (black arrowheads).
C, left panel, recombinant Reaper-GST. Middle panel, Hid-His6. Right panel, Grim-His6 were mixed with Drosophila embryo extract for 10 min.
Subsequently, recombinant DIAP1 and His-ubiquitin were added, and the mixture shifted to 37 °C for 40 min. The samples were resolved by
SDS-PAGE and blotted using indicated antibodies. Note parent species (gray arrows) and polyubiquitinated species (brackets).
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To demonstrate the biological significance of the Reaper-IAP
interaction in modulating Reaper protein levels, we examined
the relative stability of Reaper and Reaper 1–15 in Drosophila
SL2 cells. Because SL2 cells have a low transfection efficiency,
it was difficult to follow Reaper protein levels by immunoblot-
ting or radiolabeling. Therefore, we generated Reaper-GFP and
Reaper 1–15-GFP constructs under the control of a metallo-
thionine promoter to perform a fluorescence-based protein sta-
bility assay. Each Reaper construct was transfected into SL2
cells, with or without DIAP1 that was driven by the constitu-
tive baculovirus IE1 promoter. After 16 h of induction with
copper, the copper containing medium was replaced with fresh
(copper-free) medium, thereby inactivating the Reaper pro-
moter. SL2 cells were then immediately analyzed for GFP
fluorescence (and then analyzed again at 16 and 24 h). The
results of this experiment confirmed our hypothesis that wild
type Reaper was subject to DIAP1-stimulated degradation, but
Reaper 1–15 was not (Fig. 4D). An identical experiment in
which cycloheximide was used in place of copper-removal gave
similar results (data not shown). It is worth noting that Reaper
1–15 retains all five of the lysines in Reaper (Fig. 5A), so the
enhanced stability of the Reaper deletion mutant most likely
stems from its inability to interact with IAPs and not from a
lack of potential ubiquitin conjugation sites.
Ubiquitination-resistant Reaper Is Not Destabilized by
IAPs—To fully address the biological significance of this novel
mechanism for regulating Reaper levels, we wanted to ask
whether or not the ubiquitination and degradation of Reaper
per se affects its abundance and biological activity. This ques-
tion precluded the use of Reaper 1–15 because that mutant
lacks the IAP interaction domain and is therefore unable to
inhibit IAP activity or stimulate IAP degradation. We therefore
chose to construct an additional Reaper mutant that would
interact normally with the IAPs but would itself be impervious
to ubiquitination. Accordingly, we mutated all of the lysines in
Reaper to arginines (ReaperKR) to inhibit ubiquitin conjuga-
tion (Fig. 5A). As expected, ReaperKR still interacted quite
stably with DIAP1 (Fig. 5B). When ReaperKR was produced in
vitro using reticulocyte lysates, we observed that much more of
the mutant was made than wild type Reaper, suggesting that
the lysine mutations were in fact stabilizing the protein (Fig.
5C). We then expressed Reaper and ReaperKR by transient
transfection of 293T cells and observed that the ReaperKR
produced to much higher steady state levels than wild type
Reaper (Fig. 5D). Furthermore, although inhibition of the pro-
teasome with LLnL increased Reaper levels, it had no effect on
ReaperKR levels (Fig. 5D). We then performed a pulse-chase
assay in 293T cells to directly examine the intrinsic half-lives of
Reaper versus ReaperKR. As expected, the lysine mutant had a
markedly increased half-life relative to wild type Reaper (Fig.
5E). These experiments supported our hypothesis that the
ubiquitin-proteasome pathway is important for the stability of
the Reaper protein and that mutation of the lysines in Reaper
makes it resistant to degradation.
IAP Ligase Activity Contributes to Reaper Instability—If
IAPs were in fact mediating the degradation of Reaper, we
reasoned that ReaperKR should be resistant to the effects of
IAP overproduction. We therefore performed pulse-chase anal-
ysis on Reaper and ReaperKR in 293T cells that had also been
transfected with XIAP. The results from this assay confirmed
that ReaperKR was significantly more stable than the wild
type protein (Fig. 5F). In contrast, when the pulse-chase anal-
ysis was repeated using the XIAP H467A ubiquitin ligase mu-
tant, wild type Reaper was stable, implying that the destabili-
zation of Reaper was in fact specific to IAP ubiquitin-ligase
activity (Fig. 5F).
Regulation of Reaper Stability Affects Its Ability to Induce
Apoptosis—Finally, because Reaper is a potent pro-apoptotic
protein, we wanted to assay the killing ability of the degrada-
tion-resistant ReaperKR with respect to wild type Reaper. We
reasoned that if the regulation of Reaper levels by IAP-stimu-
lated ubiquitination was biologically significant, then the deg-
radation-resistant ReaperKR would be an even more potent
killer than wild type Reaper. To test this hypothesis, we first
compared the killing activities of Reaper and ReaperKR in
transfected human cells. As shown in Fig. 6A, ReaperKR was a
substantially better inducer of apoptosis than Reaper. Finally,
to assay the biological function of Reaper in the context of its
native species, we examined the relative killing activities of
Reaper and ReaperKR in Drosophila SL2 cells. Once again, the
degradation-resistant ReaperKR was a much better inducer of
caspase-dependent cell death than wild type Reaper (Fig. 6B).
Collectively, these experiments demonstrate that regulation of
Reaper by IAP-mediated ubiquitination and degradation has a
significant impact on the ability of Reaper to initiate apoptosis.
DISCUSSION
Our results implicate the ubiquitin-proteasome pathway in
the regulation of Reaper stability and biological activity. In
vitro ubiquitination assays coupled with overexpression and
mutant studies strongly suggest that IAPs such as XIAP and
DIAP1 can serve as ubiquitin ligases for Reaper, HID, and
Grim. Furthermore, the regulation of Reaper stability has a
FIG. 4. Reaper 1–15 is not an IAP substrate. A, HEK 293T cells
were co-transfected with GST-DIAP1 and 1–15 Reaper (1–15). Co-
precipitations were performed using either anti-Reaper serum (-Rpr)
or glutathione-Sepharose (GSH). The samples were resolved by SDS-
PAGE and blotted using anti-Reaper serum. Note that Fig. 2B demon-
strates co-immunoprecipitation of full-length Reaper and DIAP1. B,
untagged Reaper and Reaper 1–15 were translated in rabbit reticulo-
cyte lysate. Equal amounts of lysate were subject to immunoprecipita-
tion using anti-Reaper serum. The samples were resolved by SDS-
PAGE and exposed to film. C, reaper or Reaper 1–15 were produced in
reticulocyte lysates, cycloheximide was added, and the proteins were
incubated for a further 30 or 60 min at 30 °C. Equal volumes of reticu-
locyte lysate were immunoprecipitated with anti-Reaper serum and
processed as above. The precipitates were resolved by SDS-PAGE and
exposed to film. The results were quantified by ImageJ application
(NIH). D, Drosophila SL2 cells were transfected with either copper-
inducible Reaper-GFP or 1–15 Reaper-GFP in the presence or absence
of constitutively expressed DIAP1. At time 0, copper was removed, and
the cells were harvested at 0, 16, and 24 h and subjected to FACS
analysis to determine the percentage of GFP-positive cells. The percent-
age of Reaper-GFP in the presence of DIAP1 was determined by com-
paring the percentage of GFP to that at time 0 in cells containing DIAP1
relative to the percentage of GFP in cells lacking DIAP1. The samples
were processed and analyzed in triplicate, and the standard deviations
were used to determine error. IP, immunoprecipitation; WT, wild type.
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significant effect on the ability of Reaper to initiate apoptosis.
As such, the work reported here ascribes a new anti-apoptotic
function to the IAP RING finger domain in that it promotes the
degradation of RHG family members.
The findings reported here suggest that IAP proteins can
ubiquitinate Reaper and its relatives and that this requires a
stable interaction between the RHG protein and the IAP. We
and several other groups recently reported that the interaction
between Reaper, HID, and Grim and the IAPs can stimulate
IAP auto-ubiquitination and degradation, thereby facilitating
caspase activation and cell death (12–17). Given the ability of
Reaper to stimulate IAP degradation and vice versa, it is not
entirely clear how the outcome of the Reaper-IAP battle is
determined. Because Reaper is also transcriptionally regulated
(35–39), the balance between Reaper-mediated death and IAP-
mediated survival may be partially determined by the strength
of Reaper induction following a particular apoptotic stimulus.
Similarly, it is likely that cells with different levels and types of
IAPs will differ in their susceptibility to Reaper. Almost cer-
tainly, other modulatory factors also help to determine the
outcome of the Reaper-IAP interaction. One such candidate
factor is Morgue, a newly identified protein related to variant
ubiquitin-conjugases that was isolated in a screen for modifiers
of Reaper and Grim cell death (13, 16). This protein may assist
Reaper- and Grim-mediated IAP degradation in some way,
helping to shift the balance toward death when Morgue is
present. Also, the ability of Reaper to suppress translation may
assist in shifting the IAP-Reaper balance toward cell death.
Our data demonstrating that Reaper, HID, and Grim are all
subject to IAP-stimulated ubiquitination may help to explain
previous reports that have noted a cooperative apoptosis-induc-
ing effect when more than one RHG protein is present (40, 41).
Although it has been thought that this effect might be due to
slightly different biological functions, the data presented here
suggest that these proteins may cooperate in vivo by indirectly
modulating each other’s abundance; that is, as the RHG pro-
teins successfully stimulate ubiquitin-mediated destruction of
the IAPs, their own half-lives are extended, and they are able
FIG. 6. Lysine-deficient Reaper is a more potent inducer of
apoptosis. A, HEK 293T cells were co-transfected with GFP and vector
alone (control), Reaper, or lysine-deficient ReaperKR in the presence or
absence of the irreversible caspase inhibitor zVAD-fmk. After 48 h, the
cells were harvested and subjected to FACS analysis to determine the
percentage of GFP-positive cells. The percentage of survival was calcu-
lated by the percentage of GFP-positive cells without zVAD-fmk rela-
tive to the percentage of GFP-positive cells with zVAD-fmk. The sam-
ples were processed in duplicate, and the standard deviations were used
to determine error. B, Drosophila SL2 cells were co-transfected with
constitutively expressed GFP and metallothionine-driven Reaper,
ReaperKR, or vector control. Reaper was induced 16 h after transfection
(to allow for GFP expression), and the cells were harvested after a
further 48 h of incubation. The cells were subjected to FACS analysis as
above. The percentage of survival was calculated by dividing the per-
centage of GFP-positive induced cells by the percentage of GFP-positive
induced cells treated with zVAD-fmk. The samples were processed in
triplicate, and the standard deviations were used to determine error.
FIG. 5. Lysine-deficient Reaper exhibits increased stability. A, schematic of the Reaper protein sequence, showing the number and relative
distribution of lysines. The amino acid positions are indicated. B, HEK 293T cells were co-transfected with GST or GST-DIAP1 and lysine-deficient
Reaper (ReaperKR-FLAG). Co-precipitations were performed using either anti-FLAG antibody or glutathione-Sepharose (GSH). The samples were
resolved by SDS-PAGE and blotted using anti-FLAG antibody. C, FLAG-tagged Rpr and lysine-deficient Reaper (RprKR) were translated in rabbit
reticulocyte lysate. Equal volumes of lysate were immunoprecipitated with anti-FLAG antibody. The samples were resolved by SDS-PAGE and
exposed to film. D, HEK 293T cells were transfected with FLAG-tagged Rpr and RprKR. 45 min prior to harvest, the cells were treated with 20
M LLnL (or not). The cells were harvested, and the Reapers were precipitated using anti-FLAG antibody. The samples were resolved by
SDS-PAGE and blotted using anti-FLAG antibody. E, HEK 293T cells were transfected with Rpr or RprKR. At the indicated times, the cell lysates
were subjected to immunoprecipitation using anti-FLAG antibody to precipitate Rpr and RprKR. The samples were resolved by SDS-PAGE and
exposed to film, and the results were quantified using the ImageJ application (NIH). F, HEK 293T cells were transfected with Rpr or RprKR and
either GST-XIAP or GST-XIAP H467A. The samples were processed as in E.
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to accumulate to higher levels. This would explain the rise in
HID levels following Reaper overexpression (Fig. 1).
Interestingly, the vertebrate IAP antagonist Smac is also a
substrate for IAP-mediated ubiquitination, suggesting that
ubiquitination of IAP-binding partners may be widespread
(42). In this regard, it would be interesting to determine
whether the stability of Omi is regulated by IAP proteins as
well. Conversely, the weakly pro-apoptotic proteins Smac and
Omi have not been reported to stimulate IAP degradation. If
Smac and Omi do not, in fact, have this activity, their interac-
tion with the IAP ubiquitin-ligase would be unidirectional,
with the IAP targeting Smac and Omi for destruction, while
the IAP itself remained stable. This may be the case if
Smac and Omi do not engage the IAPs in precisely the
same way as Reaper, HID, and Grim or if a domain in addition
to the RHG motif is also required to stimulate IAP
auto-ubiquitination.
Finally, the interplay that we have described between
Reaper and the IAPs illustrates that the decision to undergo
apoptosis (or not) is an active struggle within the cell. In this
particular struggle, the outcome can be tipped one way or the
other by regulating the protein stability of these antagonistic
apoptotic regulators.
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